PATH | VRL
Menu

Clinical Testing of Pre-Pandemic Live Attenuated A/H5N2 Influenza Candidate Vaccine in Adult Volunteers: Results From a Placebo-Controlled, Randomized Double-Blind Phase I Study

This article, published in Vaccine, reports the results of a Phase 1 study examining the safety and immunogenicity of an A/H5N2 live attenuated influenza vaccine candidate. The results showed the vaccine to be safe and well tolerated in healthy volunteers and elicited an immune response. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)

Author: Rudenko L, Kiseleva I, Stukova M, et al.

Published: 2015

» Visit web page (English)

(Located at www.sciencedirect.com)

Citation: Rudenko L, Kiseleva I, Stukova M, et al. Clinical Testing of Pre-Pandemic Live Attenuated A/H5N2 Influenza Candidate Vaccine in Adult Volunteers: Results From a Placebo-Controlled, Randomized Double-Blind Phase I Study. Vaccine. 2015;33(39):5110-5117.

Resource types: Peer-reviewed journal

Diseases/vaccines: Influenza

Topics: Vaccine safety and performance, Disease/vaccine specific information

Regions: Eastern Europe